Ohio State Navbar

Quick Links

Joan-Miquel Balada-Llasat, PharmD, PhD D(ABMM)


Joan-Miquel Balada-Llasat, PharmD, PhD

Associate Director, Clinical Microbiology and Special Functions , Assistant Professor Clinical Pathology
The Ohio State University Wexner Medical Center
1492 East Broad Street
Columbus, OH 43205
P: 614-257-7285
E: Joan.Balada@osumc.edu

EDUCATION:

  • Fellowship in Clinical Microbiology at the Postgraduate Training Program at University of Washington, 2006-2008
  • Ph.D. Molecular Biology and Microbiology at Tufts University School of Medicine, 1998-2000
  • Molecular Microbiology Fellowship at Tufts University School of Medicine (Boston, MA), 1998-2000
  • Pharm.D. College of Pharmacy. University of Barcelona, Spain, 1991-1997

PROFESSIONAL MEMBERSHIPS:

  • American Society for Microbiology, 2002-present
  • European Society Clinical Microbiology and Infection Diseases, 2002-present

SPECIAL AWARDS/RECOGNITION:

  • Young Investigator award MSACL, February 2013
  • Young investigator award ACLPS, June 2007
  • Young investigator award ACLPS, June 2008

LECTURES:

  • Infectious Diseases Laboratory Diagnosis. Global One Health Ethiopia Summer institute. Addis Ababa, Ethiopia, July 2014
  • Diagnosis of Tuberculosis. Department of Microbiology, Immunology & Parasitology School of Medicine, Addis Ababa University, July 2014
  • Corrected reports. Invited by James W Snyder, South Central Association Clinical Microbiology national conference, June 2014
  • Rapid diagnosis of tuberculosis. Invited by: Janet Ikeda, Investigation, development and Integral Education Association. Quetzaltenango, Guatemala, November 2013
  • Tuberculosis diagnosis. Invited by: Dr. Nunez, STI-HIV/AIDS Program. Panama City, Panana, November 2013
  • Microbiologist: an essential member of the Antimicrobial Stewardship Program. South Central Association for Clinical Microbiology Ohio Meeting Columbus, USA, October 2013
  • Impacting Patient Care: Rapid Identification of Blood pathogens and Antimicrobial Resistance. Invited by: Dr. Sonenshein. Microbiology Department. Tufts University. Boston, USA, July 2013
  • Go the Distance: The Clinical Impact of Corrected Microbiology Reports. American Society of Microbiology Meeting. Denver, USA, May 2013
  • Practical Implementation of Molecular Tests for the Diagnosis of Infectious Diseases. South Central Association for Clinical Microbiology Meeting. Plymouth, MI, USA, April 2013
  • Diagnosis of Tuberculosis. Tuberculosis Working Group. Invited by: Dr. Torrelles. Guatemala City, September 2012
  • Tuberculosis update. Columbus, OH. South Central Association Clinical Microbiology, Ohio meeting, October 2012
  • MALDI-TOF Mass Spectrometry: Cutting-Edge Microbial Identification. Pathology Update Course. Columbus, OH, September 2012
  • Coloring Bugs. The art of infectious disease diagnosis. Histology society of Ohio Meeting. Columbus, OH, April 2012
  • Implementation of Rapid Diagnostic Techniques in the Microbiology Laboratory. Pathology Department. Invited talk. Penn State University. Hershey, Pennsylvania, September 2011
  • Respiratory Viruses and Molecular Microbiology Testing. Pathology Update Course. Columbus. OH, August 2010
  • Molecular Diagnostics in the Clinical Microbiology Laboratory. American Society of Clinical Pathologists Meeting. Columbus, OH, March 2009

GRANTS:

  • Improvement of the TB diagnosis in patients infected with HIV in Central America. Funding agency: Probitas Foundation
  • Improved diagnosis of Mycobacterium bovis infections in human and cattle. Funding agency: OSU OIA/PHPID
  • Improving Tuberculosis diagnostics in Guatemala. Funding agency: OSU OIA/PHPID
  • Prospective Clinical Evaluation of the FilmArray® Meningitis/Encephalitis (ME) Panel BioFire Study # SDY-012348. Funding agency: BioFire
  • The Ohio State University Investigator Initiated HCV Genotyping Research Study. Funding agency: Genmark
  • Evaluation of Luminex xTAG ASR(s). Funding agency: Luminex
  • Quidel Molecular Influenza A+B. Funding agency: Clinical Trial Quidel
  • Verigene Gram-Positive Bacteria Blood Culture (BC-GP) Nucleic Acid Test IUO Phase II Methods Comparison study. Funding agency: Clinical Trial Nanosphere

PUBLICATONS:  [ Click here ]